| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |